Markets:

Overview

News

Currencies

International

Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

43.34 -0.40 (-0.91%)

Streaming Delayed Price Updated: 2:17 PM EDT, Aug 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Qiagen N.V. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Qiagen, Becton Dickinson Settle Patent Infringement Lawsuit For $53M ↗

November 08, 2021

Qiagen N.V. (NYSE: QGEN) settled with Becton Dickinson & Co (NYSE: BDX) a patent infringement lawsuit related to Qiagen's NeuMoDx 96 and NeuMoDx...

Via Benzinga

Topics Intellectual Property Lawsuit

QIAGEN and BD Settle Patent Infringement Lawsuit

November 05, 2021

From QIAGEN N.V.

Via Business Wire

Qiagen NV (QGEN) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

QGEN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Qiagen Clocks 17% Increase In Non-COVID Product Sales; Raises FY21 Guidance ↗

November 04, 2021

Qiagen N.V.'s (NYSE: QGEN) Q3 revenues grew 11% Y/Y to $535 million (+10% at constant exchange rates), well above the consensus of $434.97 million. Non-COVID...

Via Benzinga

QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021

November 03, 2021

From QIAGEN N.V.

Via Business Wire

Earnings Scheduled For July 29, 2021 ↗

July 29, 2021

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...

Via Benzinga

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2

November 02, 2021

From QIAGEN N.V.

Via Business Wire

QIAGEN Strengthens UK Footprint With Move to New Manchester Facilities

October 22, 2021

From QIAGEN N.V.

Via Business Wire

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

QIAGEN N.V. to Release Results for Q3 2021 and First Nine Months of 2021

October 20, 2021

From QIAGEN N.V.

Via Business Wire

QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions

October 19, 2021

From QIAGEN N.V.

Via Business Wire

Qiagen Secures DoD Contract To Boost Production Capacity For NeuMoDx ↗

October 01, 2021

Qiagen NV (NYSE: QGEN) won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and 288 integrated PCR testing...

Via Benzinga

QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx

September 30, 2021

From QIAGEN N.V.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 ↗

October 14, 2021

Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:

Via Benzinga

Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates

September 28, 2021

Via FinancialNewsMedia

Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

September 14, 2021

Via FinancialNewsMedia

QIAGEN to Enter the DAX – Germany’s Leading Stock Market Index

September 03, 2021

From QIAGEN N.V.

Via Business Wire

QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to Date

August 23, 2021

From QIAGEN N.V.

Via Business Wire

QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR Technology

August 10, 2021

From QIAGEN N.V.

Via Business Wire

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Qiagen Inks Companion Diagnostic Development, Technology-Licensing Deal With OncXerna ↗

August 10, 2021

Qiagen NV (NYSE: QGEN) and OncXerna Therapeutics have signed a master agreement to develop a next-generation sequencing (NGS) companion diagnostic for...

Via Benzinga

QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements

August 09, 2021

From QIAGEN N.V.

Via Business Wire

Qiagen's COVID-19 Antigen Test Gets FDA Emergency Use Approval ↗

August 06, 2021

The FDA has granted emergency use authorization (EUA) to Qiagen N.V.'s (NYSE: QGEN) QIAreach SARS CoV-2 Antigen Test. The rapid, portable test can detect...

Via Benzinga

QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen

August 06, 2021

From QIAGEN N.V.

Via Business Wire

3 Must-Own Healthcare Stocks For Your Portfolio ↗

July 31, 2021

Healthcare stocks have had a steady run so far this year, with the industry’s growth prospects—based on ongoing digitization to revolutionize and increase demand—motivating investors. Thus, we believe...

Via Talk Markets

Qiagen Stock Gains As Non COVID Sales Boosts Q2 Topline, Bottom-line ↗

July 30, 2021

Qiagen N.V. (NYSE: QGEN) reported after the close of the market Thursday that its second-quarter revenues jumped 28% Y/Y as growth in its core product portfolio...

Via Benzinga

QIAGEN Reports Full Results for Q2 and H1 2021

July 29, 2021

From QIAGEN N.V.

Via Business Wire

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.